The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Second Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and Adolescence
Abstract
PURPOSE: To quantify the risk of second cancers among long-term survivors of Hodgkin’s disease (HD) diagnosed before 21 years of age and to explore sex-, age-, and site-related differences. PATIENTS AND METHODS: We analyzed data from 5,925 pediatric HD patients, including 2,646 10-year and 755 20-year survivors, who were reported to 16 population-based cancer registries in North America and Europe between 1935 and 1994. RESULTS: A total of 157 solid tumors (observed/expected ratio [O/E] = 7.0; 95% confidence interval [CI], 5.9 to 8.2.) and 26 acute leukemias (O/E = 27.4; 95% CI, 17.9 to 40.2) were reported. Risk of solid tumors remained significantly increased among 20-year survivors (O/E = 6.6, observed [O] = 40, cumulative risk = 6.5%) and persisted for 25 years (O/E = 4.6, O = 15, cumulative risk = 11.7%). Temporal trends for cancers of thyroid, female breast, bone/connective tissue, stomach, and esophagus were consistent with the late effects of radiotherapy. Greater than 50-fold increased risks were observed for tumors of the thyroid and respiratory tract (one lung and one pleura) among children treated before age 10. At older ages (10 to 16 years), the largest number of second cancers occurred in the digestive tract (O/E = 19.3) and breast (O/E = 22.9). Risk of solid tumors increased with decreasing age at HD on a relative but not absolute scale. CONCLUSION: Children and adolescents treated for HD experience significantly increased risks of second cancers at various sites for 2 to 3 decades. Although our results reflect the late effects of past therapeutic modalities, they underscore the importance of lifelong follow-up of pediatric HD patients given early, more aggressive treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
DEVITA, V. T., SERPICK, A. A., & CARBONE, P. P. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-6-881 · Cited by 1,436
Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies
Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L. M., Schneider, A. B., Tucker, M. A., & Boice, J. D. (2012) · Radiation Research · doi:10.1667/rrav05.1 · Cited by 1,124
Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies
Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L. M., Schneider, A. B., Tucker, M. A., & Boice, J. D. (1995) · Radiation Research · doi:10.2307/3579003 · Cited by 1,107
Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease
Bhatia, S., Robison, L. L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F., & Meadows, A. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341201 · Cited by 905
Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987
Thompson, D. E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., Terasaki, M., Izumi, S., et al. (1994) · Radiation Research · doi:10.2307/3578892 · Cited by 779
Risk of Second Cancers after Treatment for Hodgkin's Disease
Tucker, M. A., Coleman, C. N., Cox, R. S., Varghese, A., & Rosenberg, S. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180203 · Cited by 718
Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
Chow, W.-H., Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D., Stanford, J. L., Dubrow, R., Schoenberg, J. B., Mayne, S. T., Farrow, D. C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.150 · Cited by 626
Multiplicative Models and Cohort Analysis
Breslow, N. E., Lubin, J. H., Marek, P., & Langholz, B. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477915 · Cited by 565
Breast Cancer After Treatment of Hodgkin's Disease
Hancock, S. L., Tucker, M. A., & Hoppe, R. T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.25 · Cited by 536
Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., & Linch, D. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.498 · Cited by 476
Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen, F. E., Klokman, W. J., Hagenbeek, A., Noyon, R., van den Belt-Dusebout, A. W., van Kerkhoff, E. H., van Heerde, P., & Somers, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.2.312 · Cited by 443
Self-citationvan Leeuwen, F. E., Klokman, W. J., Veer, M. B. V., Hagenbeek, A., Krol, A. D. G., Vetter, U. A. O., Schaapveld, M., van Heerde, P., Burgers, J. M. V., Somers, R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.487 · Cited by 436
Self-citationThe epidemiology of cervical carcinogenesis
Schiffman, M. H., & Brinton, L. A. (1995) · Cancer · doi:10.1002/1097-0142(19951115)76:10+<1888::aid-cncr2820761305>3.0.co;2-h · Cited by 344
Tucker, M. A., Jones, P. H. M., Boice, J. D., Robison, L. L., Stone, B. J., Stovall, M., Jenkin, R. D. T., Lubin, J. H., Baum, E. S., & Siegel, S. E. (1991) · PubMed · Cited by 303
Boice, J. D., Preston, D., Davis, F. G., & Monson, R. R. (1991) · Radiation Research · doi:10.2307/3577890 · Cited by 299
Incidence of Female Breast Cancer among Atomic Bomb Survivors, 1950-1985
Tokunaga, M., Land, C. E., Tokuoka, S., Nishimori, I., Soda, M., & Akiba, S. (1994) · Radiation Research · doi:10.2307/3578591 · Cited by 285
Second cancers following pediatric Hodgkin's disease.
Wolden, S. L., Lamborn, K. R., Cleary, S. F., Tate, D. J., & Donaldson, S. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.536 · Cited by 268
Swerdlow, A. J., Douglas, A. J., Hudson, G. V., Hudson, B. V., Bennett, M. H., & MacLennan, K. A. (1992) · BMJ · doi:10.1136/bmj.304.6835.1137 · Cited by 241
Roles of Radiotherapy and Smoking in Lung Cancer Following Hodgkin's Disease
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Hagenbeek, A., van den Belt-Dusebout, A. W., Noyon, R., Boice, J. D., Burgers, J. M. V., & Somers, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1530 · Cited by 234
Self-citationSankila, R., Garwicz, S., Olsen, J. H., Döllner, H., Hertz, H., Kreuger, A., Langmark, F., Lanning, M., Möller, T., & Tulinius, H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1442 · Cited by 221
Mauch, P. M., Kalish, L. A., Marcus, K. J., Coleman, C. N., Shulman, L. N., Krill-Jackson, E., Come, S. E., Silver, B., Gp, C., & Tarbell, N. J. (1996) · Blood · doi:10.1182/blood.v87.9.3625.bloodjournal8793625 · Cited by 191
Incidence of Second Cancers in Patients Treated for Hodgkin's Disease
Boivin, J.-F., Hutchison, G. B., Zauber, A. G., Bernstein, L., Davis, F. G., Michel, R. P., Zanke, B., Tan, C. T. C., Fuller, L. M., Mauch, P., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.732 · Cited by 184
Meadows, A. T., Obringer, A. C., Marrero, O., Oberlin, O., Robison, L., Fossati‐Bellani, F., Green, D., Voǔte, P. A., Morris‐Jones, P., Greenberg, M., et al. (1989) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950170525 · Cited by 165
Hunger, S. P., Link, M. P., & Donaldson, S. S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2160 · Cited by 134
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty, O., Hudson, M. M., Greenwald, C., Luo, X., Fang, L., Wilimas, J. A., Thompson, E. I., Kun, L. E., & Pratt, C. B. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.603 · Cited by 130
Breast Cancer after Radiotherapy for Skin Hemangioma in Infancy
Lundell, M., Mattsson, A. F., Hakulinen, T. R., & Holm, L. (1996) · Radiation Research · doi:10.2307/3579178 · Cited by 119
Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
Kim, R., Weissfeld, J. L., Reynolds, J. C., & Kuller, L. H. (1997) · PubMed · Cited by 114
Lung cancer following Hodgkin′s disease: A case‐control study
Kaldor, J. M., Day, N., Bell, J., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520502 · Cited by 107
Cancer Following Radiotherapy for Peptic Ulcer
Griem, M. L., Kleinerman, R. A., Boice, J. D., Stovall, M. A., Shefner, D., & Lubin, J. H. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.842 · Cited by 96
Poljak, M., Cerar, A., & Seme, K. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90046-6 · Cited by 83
HLA control in the progression of human papillomavirus infections
Breitburd, F., Ramoz, N., Salmon, J., et al. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0045 · Cited by 82
Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood
Tarbell, N. J., Mauch, P., Gelber, R. D., & Weinstein, H. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90880-p · Cited by 75
Salivary Gland Cancer: A Case-Control Investigation of Risk Factors
Spitz, M. R., Fueger, J. J., Goepfert, H., & Newell, G. R. (1990) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1990.01870100057012 · Cited by 73
Kushner, B. H., Zauber, A. G., & TAN, C. T. C. (1988) · Cancer · doi:10.1002/1097-0142(19881001)62:7<1364::aid-cncr2820620721>3.0.co;2-t · Cited by 57
Chemotherapy and irradiation in childhood Hodgkin's disease.
Robinson, B. A., Kingston, J. E., Nogueira-Costa, R., Malpas, J. S., Barrett, A., & McElwain, T. J. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.12.1162 · Cited by 42
Cited by
Late cardiotoxicity after treatment for Hodgkin lymphoma
Aleman, B. M. P., van den Belt-Dusebout, A. W., De Bruin, M. L., van 't Veer, M. B., Baaijens, M. H. A., Boer, J. P. D., Hart, A. A. M., Klokman, W. J., Kuenen, M. A., Ouwens, G. M., et al. (2007) · Blood · doi:10.1182/blood-2006-07-034405 · Cited by 746
Self-citationLong-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
Aleman, B. M. P., van den Belt-Dusebout, A. W., Klokman, W. J., van’t Veer, M. B., Bartelink, H., & van Leeuwen, F. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.131 · Cited by 716
Self-citationLandier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T., Hester, A. L., Darling, J., Armstrong, F. D., Blatt, J., Constine, L. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.032 · Cited by 706
Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
Friedman, D. L., Whitton, J., Leisenring, W., Mertens, A. C., Hammond, S., Stovall, M., Donaldson, S. S., Meadows, A. T., Robison, L. L., & Neglia, J. P. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq238 · Cited by 703
Bhatia, S., Yasui, Y., Robison, L. L., Birch, J. M., Bogue, M. K., Diller, L., DeLaat, C., Fossati-Bellani, F., Morgan, E., Oberlin, O., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.059 · Cited by 613
Metadata
- Authors
- Metayer, C., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., Joensuu, T., van Leeuwen, F. E., van’t Veer, M. B., Curtis, R. E., Holowaty, E. J., Andersson, M., Wiklund, T., Gospodarowicz, M., & Travis, L. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-06-12
- Volume
- 18
- Issue
- 12
- Pages
- 2435-2443
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1955391915
- Cited by
- 340
- References
- 38
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.